CAR-T: trailblazing the path from clinical development to the clinic

被引：0
|
作者：
Samuele Butera
机构：
[1] One Health Plaza,Novartis Oncology
来源：
Gene Therapy | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：163 / 164
页数：1
相关论文
共 50 条
  • [31] CAR-T Cells
    Maloney, David G.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S100 - S101
  • [32] CAR-T cell manufacturing landscape-Lessons from the past decade and considerations for early clinical development
    Dias, Juliana
    Garcia, John
    Agliardi, Giulia
    Roddie, Claire
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (02)
  • [33] The development of remote-controlled CAR-T cells
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (03) : 502 - 502
  • [34] Development of CAR-T cell therapies for multiple myeloma
    Nico Gagelmann
    Kristoffer Riecken
    Christine Wolschke
    Carolina Berger
    Francis A. Ayuk
    Boris Fehse
    Nicolaus Kröger
    Leukemia, 2020, 34 : 2317 - 2332
  • [35] A roadmap to the development of CAR-T cell immunotherapy in Europe
    B, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S111 - S111
  • [36] CAR density influences CAR-T antitumoral efficacy and correlates with clinical outcome
    Rodriguez-Marquez, P.
    Calleja-Cervantes, M. E.
    Serrano, G.
    Palacios-Berraquero, M. L.
    Ceballos, C.
    Martin-Uriz, P. San
    Vilas-Zornoza, A.
    Martin-Mallo, A.
    Rodriguez-Diaz, S.
    Martinez-Turrillas, R.
    Jauregui, P.
    Calvino, C.
    Inoges, S.
    de Cerio, A. Lopez-Diaz
    Oliver-Caldes, A.
    Espanol-Rego, M.
    Pascal, M.
    Martin-Antonio, B.
    Juan, M.
    Urbano-Ispizua, A.
    de larrea, C. Fernandez
    Viguria, M. C.
    Redondo, M.
    Rodriguez-Otero, P.
    Rifon, J.
    Alfonso, A.
    Lasarte, J. J.
    Lozano, T.
    Hernaez, M.
    Rodriguez-Madoz, J. R.
    Prosper, F.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A37 - A38
  • [37] Emerging Strategies to Overcome Current CAR-T Therapy Dilemmas - Exosomes Derived from CAR-T Cells
    Hu, Dong
    Yang, Ruyue
    Wang, Guidan
    Li, Hao
    Fan, Xulong
    Liang, Gaofeng
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2024, 19 : 2773 - 2791
  • [38] Gp350-targeted CAR-T therapy in EBV-positive Burkitt lymphoma: pre-clinical development of gp350 CAR-T
    Wang, Jiajia
    Wang, Huiping
    Ding, Yangyang
    Cao, Nengneng
    Nan, Fengya
    Wu, Fan
    Li, Cong
    Liang, Xue
    Xiao, Meng
    Guo, Jinjing
    Gao, Zhimai
    Yan, Li
    Zhou, Tielin
    Li, Yanli
    Zhai, Zhimin
    JOURNAL OF TRANSLATIONAL MEDICINE, 2025, 23 (01)
  • [39] Answering the "Doctor, can CAR-T therapy cause cancer?" question in clinic
    Banerjee, Rahul
    Poh, Christina
    Hirayama, Alexandre, V
    Gauthier, Jordan
    Cassaday, Ryan D.
    Shadman, Mazyar
    Cowan, Andrew J.
    Till, Brian G.
    Green, Damian J.
    Kiem, Hans-Peter
    Gopal, Ajay K.
    Maloney, David G.
    BLOOD ADVANCES, 2024, 8 (04) : 895 - 898
  • [40] Challenges of driving CD30-directed CAR-T cells to the clinic
    Grover, Natalie S.
    Savoldo, Barbara
    BMC CANCER, 2018, 19
12345